Heroin-assisted treatment in Switzerland: a case study in policy change
Effectiveness bank home page. Opens new windowResearch analysis

This entry is our analysis of a study added to the Effectiveness Bank. The original study was not published by Findings; click Title to order a copy. Free reprints may be available from the authors – click prepared e-mail. The summary conveys the findings and views expressed in the study.

Links to other documents. Hover over for notes. Click to highlight passage referred to. Unfold extra text Unfold supplementary text
Copy title and link | Comment/query |

Heroin-assisted treatment in Switzerland: a case study in policy change.

Uchtenhagen A.
Addiction: 2009, 105, p. 29–37.
Unable to obtain a copy by clicking title? Try asking the author for a reprint by adapting this prepared e-mail or by writing to Dr Uchtenhagen at uchtenhagen@isgf.uzh.ch. You could also try this alternative source.

How a damaging and socially divisive drug scene in Switzerland led that country to try prescribing heroin to heroin addicts and the political and cultural processes behind this experimental programme becoming accepted practice.

Summary Background Switzerland introduced a pragmatic national drug policy when the former conservative abstinence-orientated politics proved unable to cope with an escalating number of users and related negative consequences for public health and public order. The high visibility of needle parks and the size of the acquired immune deficiency disorder (AIDS) epidemic called for a new approach and for national leadership.

Aims To describe the intentions, the process and the results of setting up the new treatment approach of prescribing heroin to treatment-resistant heroin addicts, as an example of drug policy change.

Materials and Methods A systematic collection of relevant documents is analysed and used as evidence for describing the process of policy change.

Results Measures to reduce the negative consequences of continued use and to prevent the spread of AIDS were started mainly by private initiatives and soon taken up officially in the four-pillar drug policy (including harm reduction, prevention, treatment and law enforcement). Medical prescription of heroin to chronic, treatment-resistant heroin addicts was one of the innovations, based on extensive scientific and political preparation. Detailed documentation and evaluation, ample communication of results, adaptations made on the basis of results and extensive public debate helped to consolidate the new policy and heroin-assisted treatment, in spite of its limitations as an observational cohort study. All necessary steps were taken to proceed from a scientific experiment to a routine procedure.

Discussion Comparable policy changes have been observed in a few other countries, such as The Netherlands and Germany, based on the Swiss experience, with equally positive results of heroin-assisted treatment. These experiments were designed as randomised controlled trials, comparing intravenous heroin against oral methadone, thereby demonstrating the specific value of pharmaceutical diamorphine for maintenance treatment in opiate dependence. The positive impact of policy change and the positive outcomes of heroin-assisted treatment were acknowledged increasingly nationally and internationally, but made it difficult to continue the process of adapting policy to new challenges, due to the low visibility of present drug problems and to changing political priorities.

Conclusion A major change in drug policy was effectively realised under typical conditions of a federalist country with a longstanding tradition of democratic consensus building. Facilitating factors were the size and visibility of the heroin problem, the rise of the AIDS epidemic, and a pragmatic attitude of tolerating private initiatives opening the way to official policy change.

Last revised 20 December 2010

Open Effectiveness Bank home page

Top 10 most closely related documents on this site. For more try a subject or free text search

DOCUMENT 2014 Time limiting opioid substitution therapy

DOCUMENT 2012 Medications in recovery: re-orientating drug dependence treatment

DOCUMENT 2013 Delivering recovery. Independent expert review of opioid replacement therapies in Scotland

DOCUMENT 2014 Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations

DOCUMENT 2011 Prevention and control of infectious diseases among people who inject drugs

STUDY 1998 Changing attitudes and beliefs of staff working in methadone maintenance programs

DOCUMENT 2017 Drug misuse and dependence: UK guidelines on clinical management

STUDY 2014 Drugs: international comparators

DOCUMENT 2012 Has methadone been rehabilitated?

STUDY 1996 Alternatives to non-clinical regulation: training doctors to deliver methadone maintenance treatment